GLAND PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,861 INR | +2.56% |
|
+3.34% | -3.30% |
| 05-24 | Gland Pharma Gets Zero Observations from US FDA for API Facility in Andhra Pradesh, India | MT |
| 05-23 | Jefferies Adjusts Gland Pharma's Price Target to INR2,240 From INR2,400, Keeps at Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.59B | ||||||
| 727B | ||||||
| 592B | ||||||
| 347B | ||||||
| 319B | ||||||
| 274B |
